|
|
||||||||
1 John Rankin Laboratory of Pulmonary Medicine, Department of Preventive Medicine, and 2 Department of Medicine, Section of Pulmonary and Critical Care Medicine, Clinical Sciences Center, University of Wisconsin, Madison, Wisconsin 53705
We examined whether lung
inflammatory mediators are increased during exercise and whether
pharmacological blockade can prevent exercise-induced arterial
hypoxemia (EIAH) in young athletes. Seventeen healthy athletes (9 men,
8 women; age 23 ± 3 yr) with varying degrees of EIAH completed
maximal incremental treadmill exercise tests after administration of
fexofenadine, zileuton, and nedocromil sodium or placebo in a
randomized double-blind crossover study. Lung function, arterial blood
gases, and inflammatory metabolites in plasma, urine, and induced
sputum were assessed. Drug administration did not improve EIAH or gas
exchange during exercise. At maximal exercise, oxygen saturation fell
to 91.4 ± 2.6% (drug trial) and 91.9 ± 2.1% (placebo
trial) and alveolar-arterial oxygen difference widened to 28.1 ± 6.3 Torr (drug trial) and 29.3 ± 5.7 Torr (placebo
trial). Oxygen consumption, ventilation, and other exercise
variables were similarly unaffected by drug treatment. Although plasma
histamine increased with exercise, values did not differ between
trials, and urinary leukotriene E4 and 11
-prostaglandin
F2
levels were unchanged after exercise. Postexercise
sputum revealed no significant changes in markers of inflammation.
These results demonstrate that EIAH in young athletes is not attenuated
with acute administration of drugs targeting histamine and bioactive
lipids. We conclude that airway inflammation is of insufficient
magnitude to cause impairments in gas exchange and does not appear to
be linked to EIAH in healthy young athletes.
histamine; leukotrienes; prostaglandins; pulmonary gas exchange; respiratory resistance; arterial blood gases
This article has been cited by other articles:
![]() |
A N H Hodges, B M Lynn, M S Koehle, and D C McKenzie Effects of inhaled bronchodilators and corticosteroids on exercise induced arterial hypoxaemia in trained male athletes Br. J. Sports Med., December 1, 2005; 39(12): 917 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Haverkamp, J. A. Dempsey, J. D. Miller, L. M. Romer, D. F. Pegelow, J. R. Rodman, and M. W. Eldridge Gas exchange during exercise in habitually active asthmatic subjects J Appl Physiol, November 1, 2005; 99(5): 1938 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Grissom, L. D. Richer, and M. R. Elstad The Effects of a 5-Lipoxygenase Inhibitor on Acute Mountain Sickness and Urinary Leukotriene E4 After Ascent to High Altitude Chest, February 1, 2005; 127(2): 565 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Manohar, T. E. Goetz, and A. S. Hassan NaHCO3 does not affect arterial O2 tension but attenuates desaturation of hemoglobin in maximally exercising Thoroughbreds J Appl Physiol, April 1, 2004; 96(4): 1349 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Manohar, T. E. Goetz, and A. S. Hassan Preexercise hypervolemia does not affect arterial hypoxemia in Thoroughbreds performing short-term high-intensity exercise J Appl Physiol, June 1, 2003; 94(6): 2135 - 2144. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |